Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Clinical trial NCT01005472 · COMPLETED
Trial details
- NCT number
- NCT01005472
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2018-01-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.